Clinical trials found that retatrutide caused a dose-dependent reduction in total fat mass with mean changes of 10.7 to 21.6 kg versus placebo
At 48 weeks, the 12 mg retatrutide group lost a mean of 24.2% of body weight, with 83% achieving at least 15% weight loss
Savings amounts could change depending on what Congress decides to do with the program
We are your trusted partner in keeping your workforce healthy and your business compliant in Chicago & Naperville.
Stop use and seek medical advice if you develop rash, shortness of breath, chest pain, severe swelling, persistent vomiting, or any unexpected or worsening symptoms
Targeting the glycolytic pathway, particularly as a component of combination therapy, remains a highly promising research direction in the field of cancer treatment